Asset Manager

Updated:

NavaDerm Partners

NavaDerm Partners is a Northeast-based dermatology platform consolidating five groups with over 30 physicians and 100,000 annual patient visits.

NavaDerm Partners

NavaDerm Partners was formed through the recapitalization of five dermatology groups in New York and New Jersey (per firm website). The physician-led organization is co-headed by Dr. Roy Geronemus in New York and Dr. Sapna Palep in Manhattan, who each lead their respective group practices under the platform. The platform provides comprehensive general dermatology across medical, surgical, and cosmetic procedures. The consolidated physician network now exceeds 30 dermatologists. In the most recent year the group recorded over 100,000 patient visits, indicating a large regional outpatient practice. The strategy focuses on clinical independence and quality care, rather than direct control of operations. The firm does not publicly disclose AUM, total deployment, or team size beyond physician count. The model functions as a services roll-up with no disclosed adjacent investment vehicles or philanthropic structures. No recent capital event or recruitment activity has been reported in the last 24 months. NavaDerm's structural differentiator is its physician-led governance model: the clinical leadership remains embedded in the constituent practices, distinguishing it from traditional private-equity rollups that typically install external management teams. This structure may allow greater retention of patient relationships and physician alignment.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

New York

Corporate office

New York, NY, United States

Principals

Roy Geronemus

Partner (physician lead)

Sapna Palep

Partner (physician lead)

Sector focus

Healthcare Services

Frequently asked questions

Who runs investment decisions at NavaDerm Partners?

Investment oversight appears to rest with the physician partners—Dr. Roy Geronemus and Dr. Sapna Palep—who lead the New York and Manhattan groups respectively (per firm website). The firm does not list a separate CIO or financial manager on its public materials.

How does NavaDerm source proprietary deal flow?

NavaDerm's formation involved recapitalizing existing dermatology groups in the Northeast. The firm likely sources new partners through practitioner networks and professional referrals, given its physician-led structure.

Is NavaDerm structured as a single family office or does it operate more like a venture firm?

NavaDerm Partners is best described as a services platform or operating company, not a family office or a traditional asset manager. It consolidates dermatology practices into a single entity but does not manage third-party capital or report an investment fund.

Does NavaDerm participate in fund commitments or only direct deals?

NavaDerm does not appear to make external fund commitments. Its activity is limited to operating dermatology practices directly.

What investment stages does NavaDerm typically target?

NavaDerm targets mature dermatology groups seeking consolidation. The firm does not engage in early-stage venture or start-up practices.

Which sectors does NavaDerm explicitly avoid?

The firm operates exclusively in dermatology. It has no disclosed exposure to other healthcare segments, such as primary care or dental, nor to non-healthcare sectors.

How is NavaDerm related to the sponsoring investor?

The firm's website does not name the recapitalization partner. The ownership structure beyond the physician partners is not publicly disclosed.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo